Publikationen, an denen er mitarbeitet MARIA PILAR GONZALEZ CABO (2)

2020

  1. Thioredoxin and glutaredoxin systems as potential targets for the development of new treatments in Friedreich’s ataxia

    Antioxidants, Vol. 9, Núm. 12, pp. 1-25

2017

  1. Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich's ataxia patients

    Scientific Reports, Vol. 7, Núm. 1